ZIVO Bioscience (NASDAQ:ZIVO) Stock Crosses Below 50 Day Moving Average - Time to Sell?

Key Points

• ZIVO Bioscience shares fell below their fifty-day moving average of $14.97, trading as low as $13.50.
• The company has a market capitalization of $53.89 million and a P/E ratio of -2.87, indicating negative earnings.
• ZIVO Bioscience focuses on licensing and selling natural bioactive ingredients from proprietary algae cultures for applications in animal and human health.

ZIVO Bioscience, Inc. (NASDAQ:ZIVO - ) shares passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $14.97 and traded as low as $13.50. ZIVO Bioscience shares last traded at $13.99, with a volume of 300 shares trading hands.

ZIVO Bioscience Price Performance

The stock has a market capitalization of $53.89 million, a P/E ratio of -2.87 and a beta of -0.03. The company has a 50 day simple moving average of $14.97 and a 200-day simple moving average of $15.05.

ZIVO Bioscience Company Profile

ZIVO Bioscience, Inc, a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.